McKinnon Emilie, Moore Alfred, Dixit Suraj, Zhu Yun, Broome Ann-Marie
Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA.
Center of Biomedical Imaging, Medical University of South Carolina, Charleston, SC, USA.
Methods Mol Biol. 2017;1530:283-305. doi: 10.1007/978-1-4939-6646-2_17.
Optical imaging strategies, such as fluorescence and bioluminescence imaging, are non-invasive, in vivo whole body imaging techniques utilized to study cancer. Optical imaging is widely used in preclinical work because of its ease of use and cost-friendliness. It also provides the opportunity to study animals and biological responses longitudinally over time. Important considerations include depth of tissue penetration, photon scattering, absorption and the choice of light emitting probe, all of which affect the resolution (image quality and data information) and the signal to noise ratio of the image. We describe how to use bioluminescence and fluorescence imaging to track a chemotherapeutic delivery nanocarrier conjugated with a fluorophore to determine its localization in vivo.
光学成像策略,如荧光成像和生物发光成像,是用于研究癌症的非侵入性体内全身成像技术。由于其易于使用且成本低廉,光学成像在临床前研究中被广泛应用。它还提供了随时间纵向研究动物和生物反应的机会。重要的考虑因素包括组织穿透深度、光子散射、吸收以及发光探针的选择,所有这些都会影响分辨率(图像质量和数据信息)以及图像的信噪比。我们描述了如何使用生物发光和荧光成像来追踪与荧光团共轭的化疗递送纳米载体,以确定其在体内的定位。